SILENCE: On-Demand Seizure Suppression via Closed-Loop Sonogenetics
ISEF · 2026 Cellular and Molecular Biology
Overview
Epilepsy affects over 50 million people, and one in three cannot stop their seizures with medication. Neuromodulatory therapies are the leading alternative, but development has been bottlenecked by experiments that are slow and expensive. To overcome this constraint, I developed SILENCE: the first low-cost sonogenetic platform to rapidly optimize neuromodulatory therapies in vivo. SILENCE operates across three parametrizable layers in the acr-2(n2420) Caenorhabditis elegans seizure model. MscL(G22S), a gain-of-function bacterial mechanosensitive channel, was integrated into GABAergic neurons via CRISPR/FLInt safe-harbor knock-in under unc-47p. This step converts low-intensity ultrasound (US) into a circuit-restricted inhibitory signal. A custom RF-amplified transducer rig delivers US trains with tunable control of parameters relevant to therapeutic neuromodulation. A Python controller computes a motion-energy seizure index and fires US only when clustered events cross an adaptive threshold. Under a factorial US × actuator design (n = 12 per condition), post-trigger seizure recurrence dropped 70.1% (Mann-Whitney p = 0.00000074) and seizure rate dropped 29.8% (US × MscL interaction p = 0.000469). Sweeping US train duration from 100 to 2000 ms, SILENCE identified stimulation optima. An orthogonal levamisole assay confirmed the effect was driven by sonogenetic activation rather than baseline strain differences (p < 0.0001). Each run costs under 2 dollars and takes 5 minutes. At that throughput, SILENCE can compress months of neuromodulation research into hours of benchtop science, accelerating therapy development across neuromodulatory modalities. SILENCE unlocks therapeutic neuromodulation for nonspecialist labs worldwide and for the patients waiting for effective options.
Awards (3)
- First Award of $6,000 $6,000
- Mary Sue Coleman Award
- Herschbach SIYSS Award
Competition history
- ISEF 2026
Resources
Related projects
ISEF · 2017
Assessing Epilepsy Medicine by Measuring the Planarian Neural Activity Using Suction Electrode and Patch Clamp Amplifier
ISEF · 2020
Real-Time Seizure Forecasting for Epileptics on a Consumer Product
ISEF · 2026
NeuroShield: Personalized Adaptive Filtration and Clinical Trigger Mapping for Photosensitive Epilepsy
ISEF · 2025
A Scalable, Cost-Effective and Noninvasive Optogenetic Platform for Probing Synaptic Plasticity in Neurodegenerative Disease Research
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair